(Q50464203)

http://europepmc.org/abstract/MED/25069786

14 March 2018

title

Metabolism and urinary disposition of N,N-dimethyltryptamine after oral and smoked administration: a comparative study. (English)

1 reference

http://europepmc.org/abstract/MED/25069786

14 March 2018

author

Jordi Riba

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069786%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

José Carlos Bouso

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069786%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

Ethan H McIlhenny

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069786%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Steven A Barker

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069786%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

publication date

28 July 2014

1 reference

http://europepmc.org/abstract/MED/25069786

14 March 2018

published in

Drug Testing and Analysis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069786%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069786%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069786%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

page(s)

401-406

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069786%20AND%20SRC:MED&resulttype=core&format=json

LC/MS/MS analysis of the endogenous dimethyltryptamine hallucinogens, their precursors, and major metabolites in rat pineal gland microdialysate

31 May 2020

cites work

1 reference

A critical review of reports of endogenous psychedelic N, N-dimethyltryptamines in humans: 1955-2010.

21 January 2018

1 reference

Dimethyltryptamin: its metabolism in man; the relation to its psychotic effect to the serotonin metabolism

21 January 2018

1 reference

Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale

21 January 2018

1 reference

Agonist-trafficking and hallucinogens.

21 January 2018

1 reference

Monoamine oxidase inhibition in brain and liver produced by beta-carbolines: structure-activity relationships and substrate specificity

21 January 2018

1 reference

Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca

21 January 2018

1 reference

Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers

21 January 2018

1 reference

Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics

21 January 2018

1 reference

Dimethyltryptamine (DMT): prevalence, user characteristics and abuse liability in a large global sample

21 January 2018

1 reference

The globalization of ayahuasca: harm reduction or benefit maximization?

21 January 2018

1 reference

Observations on the metabolism of the psychotomimetic indolealkylamines: implications for future clinical studies

21 January 2018

1 reference

Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca

21 January 2018

1 reference

Methodology for and the determination of the major constituents and metabolites of the Amazonian botanical medicine ayahuasca in human urine.

21 January 2018

1 reference

Psychometric assessment of the Hallucinogen Rating Scale.

21 January 2018

1 reference

Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance

21 January 2018

1 reference

Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects

21 January 2018

1 reference

4-Bromo-2,5-dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effects

21 January 2018

1 reference

Effect of Some Indolealkylamines on Man

21 January 2018

1 reference

N, N-dimethyltryptamine: an endogenous hallucinogen.

21 January 2018

2 references

21 January 2018

7 January 2021

In vivo metabolism of 5-methoxy-N,N-dimethyltryptamine and N,N-dimethyltryptamine in the rat.

1 reference

5-Methoxytryptamine is metabolized by monoamine oxidase A in the pineal gland and plasma of golden hamsters.

21 January 2018

1 reference

Tissue distribution, metabolism and effects of bufotenine administered to rats

21 January 2018

1 reference

21 January 2018

Oxidative N-dealkylation

1 reference

7 January 2021

Metabolism of the hallucinogen N,N-dimethyltryptamine in rat brain homogenates

1 reference

7 January 2021

Urinary excretion of 5-methoxy-N,N-dimethyltryptamine, N,N-dimethyltryptamine and their N-oxides in the rat

1 reference

7 January 2021

Study of metabolism of psychotomimetic indolealkylamines by rat tissue extracts using liquid chromatography

1 reference

7 January 2021

Observations on the fate of indolalkylamines in the organism

1 reference

7 January 2021